Major histocompatibility complex class II presenting ovalbumin-derived peptides (MHC II-OVA)

The Major histocompatibility complex class II presenting ovalbumin-derived peptides is a molecular complex formed by the association of an MHC class II heterodimer with a specific peptide fragment, typically OVA 323-339, derived from the chicken egg white protein ovalbumin (UniProt: P01012). This complex is expressed on the surface of professional antigen-presenting cells, such as dendritic cells and B cells, following the endocytic uptake and proteolytic processing of the ovalbumin protein (PubMed: 15661914). Its primary function is to serve as the cognate ligand for the T-cell receptor (TCR) of CD4+ T helper cells, a process essential for the initiation and regulation of the adaptive immune response (StatPearls: NBK541069). Although ovalbumin is a foreign protein and not a direct human disease target, this specific peptide-MHC complex is the most widely utilized model system in immunology for studying antigen recognition, peripheral tolerance, and the development of vaccines (PubMed: 25108025). In drug discovery research, it serves as a prototype for developing TCR-like antibodies and chimeric antigen receptor (CAR) T-cell therapies that target specific peptide-MHC complexes on diseased cells. The interaction between this complex and the TCR is a fundamental mechanism for inducing immune-mediated cell death or immune modulation in various therapeutic contexts. This model is particularly crucial for evaluating the efficacy of immunotherapies designed to modulate T-cell responses in conditions like allergy and autoimmunity. By mimicking the presentation of a known antigen, researchers can precisely measure the potency and specificity of novel immunomodulatory agents.

Other names

MHC II-OVA complexpMHC II (OVA)I-A/OVA complexHLA-DR/OVA complexOvalbumin peptide-MHC class II complexOVA 323-339/MHC II complexMHC class II-restricted ovalbumin peptide complex

The complex acts as a ligand for the T-cell receptor (TCR) on CD4+ T cells, triggering signal transduction pathways that lead to T-cell activation, proliferation, and cytokine production (PubMed: 15661914).